USPTO serial 79061953
ERREGIERRE
Reviewed by CopyMark Law Group
Reg. 3612747Status 706Registered
- Filing date
- Status date
- Registration date
- Apr 28, 2009
- Examiner
- MICHELI, ANGELA M
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with ERREGIERRE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
I-24060 SAN PAOLO D'ARGON (BG), IT
I-24060 SAN PAOLO D'ARGON (BG), IT
SAN PAOLO D'ARGON (BG), IT
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence E. Abelman
Lawrence E. Abelman Abelman Frayne & Schwab666 Third Avenue 10th FloorNew York, NY 10017-5621UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for industrial purposes, chemicals for use in the manufacture of principle active ingredients, chemicals for use in industry, [ chemicals for use in the biochemical and chemical industry, chemicals for use in biotechnological manufacturing processes, ] chemicals used in industry | ACTIVE | — |
| 005 | Antiarrhythmics, anticoagulants, anticonvulsants, antidepressants, [ antidiabetic preparations, ] antiemetics, [ antifungal creams for medical use, antihistamines, ] antihypertensives, antipyretic analgesics, anti-diabetic pharmaceuticals, [ anti-diabetic preparations, anti-inflammatories, anti-inflammatory and antipyretic preparations, anti-inflammatory gels, anti-inflammatory ointments, appetite suppressants, ] beta blockers, bronchial dilators, bronchodilators, cardiovascular pharmaceuticals, [ cardiovascular treatment preparations, ] cholesterol reducers, [ dermatological pharmaceutical products, dermatologicals, eye drops, ] fungicides for medical use, [ muscle relaxants, nausea treatment preparations, ophthalmic preparations, ophthalmologic preparations, ophthalmological preparations, pharmaceutical preparations, namely, anticoagulants, pharmaceutical preparations, namely, antidepressants, pharmaceutical preparations, namely, appetite suppressants, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations active on the central nervous system, pharmaceutical preparations and ] substances for the treatment of gastro-intestinal diseases [, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophtalmology and for gastroenterological disorders, pharmaceutical preparations for skin care, pharmaceutical products for opthalmological use, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical skin lotions, vaginal preparations, namely, antifungals ] | ACTIVE | — |
| 042 | Chemical analysis, [ chemical laboratories, chemical research, ] development of new technology for others in the field of custom synthesis, [ development of pharmaceutical preparations and medicines, ] laboratory research in the field of chemistry, [ medical and scientific research, namely, conducting clinical trials, medical and scientific research in the field of medical imaging, ] product development, product research, product research and development, research and development for new products for others, research and development of new products, research in the field of chemistry [, research on the subject of pharmaceuticals, testing, inspection or research of pharmaceuticals, cosmetics or foodstuff ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ERREGIERRE S.P.A.
- Other trademarks owned by ERREGIERRE S.P.A.
- Other trademarks owned by ERREGIERRE S.P.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ERREGIERRE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 31, 2020 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jan 8, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 8, 2019 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 8, 2019 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 29, 2019 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 20, 2018 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 28, 2018 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 21, 2017 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 1, 2016 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 1, 2016 | INPC | INVALIDATION PROCESSED | — |
| May 29, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 29, 2015 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 29, 2015 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 29, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 20, 2015 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 28, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 10, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 3, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 3, 2009 | ALIE | ASSIGNED TO LIE | — |
| Dec 20, 2008 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 17, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 16, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 15, 2008 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Dec 12, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |